Immunosenescence, suppression and tumour progression
- 6 December 2005
- journal article
- review article
- Published by Springer Science and Business Media LLC in Cancer Immunology, Immunotherapy
- Vol. 55 (8), 981-986
- https://doi.org/10.1007/s00262-005-0109-3
Abstract
There are good arguments for suggesting that two seminal papers published 50 years ago can be taken as the beginning of modern tumour immunology. These papers by R. Baldwin, “Immunity to transplanted tumour: the effect of tumour extracts on the growth of homologous tumours in rats” and “Immunity to methylcholanthrene-induced tumours in inbred rats following atrophy and regression of the implanted tumours” (Br J Cancer 9:646–51 and 652–657, 1955) showed that once tumours are established, they and their products can be recognised by the adaptive immune system and rejected. However, the tumour normally co-evolves with immunity, like a parasite, rather than being suddenly introduced as in these, and many other, experimental models. Dynamics of this co-evolution are illustrated by findings that inflammation enhances tumorigenicity, yet is important to enable T cells to respond properly to tumour antigen and exert anti-tumour effects. The important thing is to maintain the balance between effective anti-tumour immunity and tumour escape and/or stimulatory mechanisms. Tumours almost always co-exist with immune defence systems over extended periods and interact chronically with T cells. The effect of this is potentially similar to other situations of chronic antigenic stress, particularly lifelong persistent virus infection, most strikingly, CMV infection. The questions briefly explored in this symposium paper are what happens when T lymphocyte clones are chronically stimulated by antigen which is not or cannot be eliminated? What are the similarities and differences between chronic antigenic stimulation by tumour antigen versus CMV antigen? What can we learn in one system which may illuminate the other?Keywords
This publication has 24 references indexed in Scilit:
- High frequencies of functionally impaired cytokeratin 18-specific CD8+ T cells in healthy HLA-A2+ donorsEuropean Journal of Immunology, 2005
- Human immunosenescence: is it infectious?Immunological Reviews, 2005
- Dysfunctional CMV-specific CD8+ T cells accumulate in the elderlyExperimental Gerontology, 2004
- Cellular Immune Response of Fetuses to CytomegalovirusPediatric Research, 2004
- Lack of proliferative capacity of human effector and memory T cells expressing killer cell lectinlike receptor G1 (KLRG1)Blood, 2002
- Have tumor cells learnt from microorganisms how to fool the immune system?Molecular Medicine Today, 2000
- Tumor Infiltrating Lymphocytes in Melanoma Comprise High Numbers of T-Cell Clonotypes That Are Lost during in Vitro CultureClinical Immunology, 2000
- Role of Cytomegalovirus in the T Cell Changes Seen in Elderly IndividualsClinical Immunology, 1999
- Clonal populations of T cells in normal elderly humans: the T cell equivalent to "benign monoclonal gammapathy".The Journal of Experimental Medicine, 1994
- DY determinants, possibly associated with novel class II molecules, stimulate autoreactive CD4+ T cells with suppressive activity.The Journal of Experimental Medicine, 1988